Furst DE - Search Results

1

Reliability, validity, and minimally important differences of the SF-6D in systemic sclerosis.

Khanna D, Furst DE, Wong WK, Tsevat J, Clements PJ, Park GS, Postlethwaite AE, Ahmed M, Ginsburg S, Hays RD; Scleroderma Collagen Type 1 Study Group. Khanna D, et al. Among authors: furst de. Qual Life Res. 2007 Aug;16(6):1083-92. doi: 10.1007/s11136-007-9207-3. Epub 2007 Apr 3. Qual Life Res. 2007. PMID: 17404896 Clinical Trial.

2

A syndrome resembling progressive systemic sclerosis after bone marrow transplantation. A model for scleroderma?

Furst DE, Clements PJ, Graze P, Gale R, Roberts N. Furst DE, et al. Arthritis Rheum. 1979 Aug;22(8):904-10. doi: 10.1002/art.1780220815. Arthritis Rheum. 1979. PMID: 37843

3

Association of HLA antigen a9 with progressive systemic sclerosis (scleroderma).

Clements PJ, Opelz G, Terasaki PI, Mickey MR, Furst D. Clements PJ, et al. Tissue Antigens. 1978 Apr;11(4):357-61. doi: 10.1111/j.1399-0039.1978.tb01268.x. Tissue Antigens. 1978. PMID: 78536

4

Echocardiographic features of progressive systemic sclerosis (PSS). Correlation with hemodynamic and postmortem studies.

Smith JW, Clements PJ, Levisman J, Furst D, Ross M. Smith JW, et al. Am J Med. 1979 Jan;66(1):28-33. doi: 10.1016/0002-9343(79)90478-9. Am J Med. 1979. PMID: 154294 No abstract available.

5

Oral radiographic changes in patients with progressive systemic sclerosis (scleroderma).

White SC, Frey NW, Blaschke DD, Ross MD, Clements PJ, Furst DE, Paulus HE. White SC, et al. Among authors: furst de. J Am Dent Assoc. 1977 Jun;94(6):1178-82. doi: 10.14219/jada.archive.1977.0367. J Am Dent Assoc. 1977. PMID: 266529

6

Measurement of clinical change in progressive systemic sclerosis: a 1 year double-blind placebo-controlled trial of N-acetylcysteine.

Furst DE, Clements PJ, Harris R, Ross M, Levy J, Paulus HE. Furst DE, et al. Ann Rheum Dis. 1979 Aug;38(4):356-61. doi: 10.1136/ard.38.4.356. Ann Rheum Dis. 1979. PMID: 386962 Free PMC article. Clinical Trial.

7

Muscle disease in progressive systemic sclerosis: diagnostic and therapeutic considerations.

Clements PJ, Furst DE, Campion DS, Bohan A, Harris R, Levy J, Paulus HE. Clements PJ, et al. Among authors: furst de. Arthritis Rheum. 1978 Jan-Feb;21(1):62-71. doi: 10.1002/art.1780210111. Arthritis Rheum. 1978. PMID: 623695

8

Why everything (or nothing) seems to work in the treatment of scleroderma.

Seibold JR, Furst DE, Clements PJ. Seibold JR, et al. Among authors: furst de. J Rheumatol. 1992 May;19(5):673-6. J Rheumatol. 1992. PMID: 1613694 No abstract available.

9

Cardiac score. A semiquantitative measure of cardiac involvement that improves prediction of prognosis in systemic sclerosis.

Clements PJ, Lachenbruch PA, Furst DE, Paulus HE, Sterz MG. Clements PJ, et al. Among authors: furst de. Arthritis Rheum. 1991 Nov;34(11):1371-80. doi: 10.1002/art.1780341105. Arthritis Rheum. 1991. PMID: 1835389

10

Elevated serum levels of soluble interleukin 2 receptor, interleukin 2 and neopterin in diffuse and limited scleroderma: effects of chlorambucil.

Clements PJ, Peter JB, Agopian MS, Telian NS, Furst DE. Clements PJ, et al. Among authors: furst de. J Rheumatol. 1990 Jul;17(7):908-10. J Rheumatol. 1990. PMID: 2213757

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

734 results

Search Page

Filters